EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Midpregnancy maternal circulating angiogenic biomarkers: Associations with placental dysfunction-related pregnancy complications and fetal sex

Birgitte Kordt Sundet, Karin C Lødrup Carlsen, Guttorm Haugen, Gunilla Hedlin, Katarina Hilde, Christine M Jonassen, Björn Nordlund, Eva Maria Rehbinder, Corina Silvia Rueegg, Katrine Sjøborg, Håvard O Skjerven, Cilla Söderhäll und 5 weitere

Placenta · 2025

DOI: 10.1016/j.placenta.2025.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Birgitte Kordt Sundet und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Obstetrics and Gynaecology, Oslo University Hospit…. Hauptthemen laut MEDLINE: Placenta Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Pregnancy Complications, Placenta Diseases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Non-US Government Research Support type, Norges Forskningsråd, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Placental function differs by fetal sex, and placental dysfunction is associated with adverse pregnancy outcomes. We aimed to investigate the role of midpregnancy maternal circulating placenta-associated angiogenic biomarkers and fetal sex in relation to placental dysfunction-related pregnancy complications. METHODS: The Preventing Atopic Dermatitis and Allergies in children birth cohort study provided maternal serum from 2511 pregnancies at gestational weeks 16-22. Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were analyzed by immunoassays. Pregnancy complications (n = 385) included gestational hypertension, preeclampsia, preterm delivery, and/or newborn weight 0.05). CONCLUSION: Circulating midpregnancy placenta-associated angiogenic biomarkers differed by fetal sex and pregnancy complications. The higher risk of pregnancy complications with low midpregnancy PlGF and/or sFlt-1 levels was not influenced by fetal sex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Placenta Growth FactorVascular Endothelial Growth Factor Receptor-1Pregnancy ComplicationsPlacenta DiseasesPlacentaHumansFemalePregnancyBiomarkersAdultMaleInfant, NewbornPregnancy Trimester, Second

Stichwörter der Autor:innen

Fetal sexPlGFPlacental dysfunctionPreeclampsiaSexual dimorphismsFlt-1

Substanzen

BiomarkersPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1FLT1 protein, humanPGF protein, human

Autor:innen und Institutionen

  • Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.
  • Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, Kalnes, Norway; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
  • Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Dermatology, Oslo University Hospital, Oslo, Norway.
  • Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.

Förderung

  • Non-US Government Research Support type
  • Norges Forskningsråd
  • European Commission
  • Roche
  • Insamlingsstiftelsen Cancer- och Allergifonden
  • Sykehuset Østfold
  • Oslo universitetssykehus HF
  • Magnus Bergvalls Stiftelse

Zitieren

APA

Sundet, B. K., Lødrup Carlsen, K. C., Haugen, G., Hedlin, G., Hilde, K., Jonassen, C. M., Nordlund, B., Rehbinder, E. M., Rueegg, C. S., Sjøborg, K., Skjerven, H. O., Söderhäll, C., Vettukattil, R., Værnesbranden, M. R., Wiik, J., Staff, A. C., & Sugulle, M. (2025). Midpregnancy maternal circulating angiogenic biomarkers: Associations with placental dysfunction-related pregnancy complications and fetal sex. Placenta. https://doi.org/10.1016/j.placenta.2025.09.006

Vancouver

Sundet BK, Lødrup Carlsen KC, Haugen G, Hedlin G, Hilde K, Jonassen CM, et al. Midpregnancy maternal circulating angiogenic biomarkers: Associations with placental dysfunction-related pregnancy complications and fetal sex. Placenta. 2025. doi:10.1016/j.placenta.2025.09.006

BibTeX
@article{Sundet2025,
  author = {Sundet, Birgitte Kordt and Lødrup Carlsen, Karin C and Haugen, Guttorm and Hedlin, Gunilla and Hilde, Katarina and Jonassen, Christine M and Nordlund, Björn and Rehbinder, Eva Maria and Rueegg, Corina Silvia and Sjøborg, Katrine and Skjerven, Håvard O and Söderhäll, Cilla and Vettukattil, Riyas and Værnesbranden, Magdalena R and Wiik, Johanna and Staff, Anne Cathrine and Sugulle, Meryam},
  title = {Midpregnancy maternal circulating angiogenic biomarkers: Associations with placental dysfunction-related pregnancy complications and fetal sex},
  journal = {Placenta},
  year = {2025},
  doi = {10.1016/j.placenta.2025.09.006}
}
Kostenlos starten →